Literature DB >> 27149507

Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes.

Shraddha Sharma1, Santosh K Patnaik2, Zeynep Kemer1, Bora E Baysal1.   

Abstract

APOBEC3A cytidine deaminase induces site-specific C-to-U RNA editing of hundreds of genes in monocytes exposed to hypoxia and/or interferons and in pro-inflammatory macrophages. To examine the impact of APOBEC3A overexpression, we transiently expressed APOBEC3A in HEK293T cell line and performed RNA sequencing. APOBEC3A overexpression induces C-to-U editing at more than 4,200 sites in transcripts of 3,078 genes resulting in protein recoding of 1,110 genes. We validate recoding RNA editing of genes associated with breast cancer, hematologic neoplasms, amyotrophic lateral sclerosis, Alzheimer disease and primary pulmonary hypertension. These results highlight the fundamental impact of APOBEC3A overexpression on human transcriptome by widespread RNA editing.

Entities:  

Keywords:  Cytidine deaminase; RNA editing; RNA seq; disease genes; epitranscriptomics

Mesh:

Substances:

Year:  2016        PMID: 27149507      PMCID: PMC5449087          DOI: 10.1080/15476286.2016.1184387

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  29 in total

1.  An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

Authors:  Adam Jarmuz; Ann Chester; Jayne Bayliss; Jane Gisbourne; Ian Dunham; James Scott; Naveenan Navaratnam
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

2.  APOBEC3 proteins inhibit human LINE-1 retrotransposition.

Authors:  Heide Muckenfuss; Matthias Hamdorf; Ulrike Held; Mario Perkovic; Johannes Löwer; Klaus Cichutek; Egbert Flory; Gerald G Schumann; Carsten Münk
Journal:  J Biol Chem       Date:  2006-05-30       Impact factor: 5.157

3.  Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.

Authors:  Hal P Bogerd; Heather L Wiegand; Amy E Hulme; José L Garcia-Perez; K Sue O'Shea; John V Moran; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-25       Impact factor: 11.205

Review 4.  Functions and regulation of RNA editing by ADAR deaminases.

Authors:  Kazuko Nishikura
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

5.  Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.

Authors:  Julie Lucifora; Yuchen Xia; Florian Reisinger; Ke Zhang; Daniela Stadler; Xiaoming Cheng; Martin F Sprinzl; Herwig Koppensteiner; Zuzanna Makowska; Tassilo Volz; Caroline Remouchamps; Wen-Min Chou; Wolfgang E Thasler; Norbert Hüser; David Durantel; T Jake Liang; Carsten Münk; Markus H Heim; Jeffrey L Browning; Emmanuel Dejardin; Maura Dandri; Michael Schindler; Mathias Heikenwalder; Ulrike Protzer
Journal:  Science       Date:  2014-02-20       Impact factor: 47.728

6.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

Review 7.  Deciphering the functions and regulation of brain-enriched A-to-I RNA editing.

Authors:  Jin Billy Li; George M Church
Journal:  Nat Neurosci       Date:  2013-10-28       Impact factor: 24.884

8.  APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells.

Authors:  Gregory Berger; Stéphanie Durand; Guillaume Fargier; Xuan-Nhi Nguyen; Stéphanie Cordeil; Serge Bouaziz; Delphine Muriaux; Jean-Luc Darlix; Andrea Cimarelli
Journal:  PLoS Pathog       Date:  2011-09-22       Impact factor: 6.823

9.  APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages.

Authors:  Shraddha Sharma; Santosh K Patnaik; R Thomas Taggart; Eric D Kannisto; Sally M Enriquez; Paul Gollnick; Bora E Baysal
Journal:  Nat Commun       Date:  2015-04-21       Impact factor: 14.919

10.  A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes.

Authors:  Lily Bazak; Ami Haviv; Michal Barak; Jasmine Jacob-Hirsch; Patricia Deng; Rui Zhang; Farren J Isaacs; Gideon Rechavi; Jin Billy Li; Eli Eisenberg; Erez Y Levanon
Journal:  Genome Res       Date:  2013-12-17       Impact factor: 9.043

View more
  24 in total

1.  RNA in Disease and development.

Authors:  Andrea Barta; Michael F Jantsch
Journal:  RNA Biol       Date:  2017-05-04       Impact factor: 4.652

2.  Programmable C-to-U RNA editing using the human APOBEC3A deaminase.

Authors:  Xinxin Huang; Junjun Lv; Yongqin Li; Shaoshuai Mao; Zhifang Li; Zhengyu Jing; Yidi Sun; Xiaoming Zhang; Shengxi Shen; Xinxin Wang; Minghui Di; Jianyang Ge; Xingxu Huang; Erwei Zuo; Tian Chi
Journal:  EMBO J       Date:  2020-10-15       Impact factor: 11.598

Review 3.  When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference.

Authors:  Yumeng Wang; Han Liang
Journal:  Bioessays       Date:  2017-12-27       Impact factor: 4.345

4.  Mitochondrial complex II regulates a distinct oxygen sensing mechanism in monocytes.

Authors:  Shraddha Sharma; Jianming Wang; Eduardo Cortes Gomez; Robert T Taggart; Bora E Baysal
Journal:  Hum Mol Genet       Date:  2017-04-01       Impact factor: 6.150

5.  Human C-to-U Coding RNA Editing Is Largely Nonadaptive.

Authors:  Zhen Liu; Jianzhi Zhang
Journal:  Mol Biol Evol       Date:  2018-04-01       Impact factor: 16.240

6.  Replication catastrophe induced by cyclic hypoxia leads to increased APOBEC3B activity.

Authors:  Samuel B Bader; Tiffany S Ma; Charlotte J Simpson; Jiachen Liang; Sakura Eri B Maezono; Monica M Olcina; Francesca M Buffa; Ester M Hammond
Journal:  Nucleic Acids Res       Date:  2021-07-21       Impact factor: 16.971

7.  The double-domain cytidine deaminase APOBEC3G is a cellular site-specific RNA editing enzyme.

Authors:  Shraddha Sharma; Santosh K Patnaik; Robert T Taggart; Bora E Baysal
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

8.  Stem-loop structure preference for site-specific RNA editing by APOBEC3A and APOBEC3G.

Authors:  Shraddha Sharma; Bora E Baysal
Journal:  PeerJ       Date:  2017-12-06       Impact factor: 2.984

Review 9.  Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.

Authors:  Cody J Warren; Joseph A Westrich; Koenraad Van Doorslaer; Dohun Pyeon
Journal:  Viruses       Date:  2017-08-21       Impact factor: 5.048

10.  Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.

Authors:  Takahide Kouno; Tania V Silvas; Brendan J Hilbert; Shivender M D Shandilya; Markus F Bohn; Brian A Kelch; William E Royer; Mohan Somasundaran; Nese Kurt Yilmaz; Hiroshi Matsuo; Celia A Schiffer
Journal:  Nat Commun       Date:  2017-04-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.